 |
|
Trends in Medication Use Among US Adults With Diabetes Mellitus: Glycemic Control at the Expense of Controlling Cardiovascular Risk Factors
Devin M. Mann, MD, MS;
Mark Woodward, PhD;
Fen Ye, MS;
Marie Krousel-Wood, MD;
Paul Muntner, PhD
Arch Intern Med. 2009;169(18):1718-1720.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Successful reduction of cardiovascular disease (CVD) risk among people with diabetes mellitus is increasingly reliant on combination pharmacotherapy targeting its major risk factors, especially hypertension and high cholesterol level.1 The impact of tight hyperglycemia control on CVD and mortality risk is currently unclear, but its control is a major part of comprehensive diabetes care and is also increasingly attained through combination therapy.2-4 We sought to examine the competing treatment priorities for US adults with diabetes by analyzing the use of antidiabetes, antihypertensive, and statin medications over time from the population-based National Health and Nutrition Examination Survey (NHANES) between 1999 and 2006.
Methods
NHANES 1999-2000, 2001-2002, 2003-2004, and 2005-2006 are serial cross-sectional surveys including nationally representative samples of the noninstitutionalized civilian US population identified through a stratified, multistage probability sampling design.5 The present analysis was . . . [Full Text of this Article]
Results
Comment
AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
